OM Maya
OM Maya, part of the OM Group, stands out as a distinguished venture investment firm. With a focus on venture creation activities and early-stage investments, OM Maya is dedicated to fostering innovation and growth within its portfolio companies.
Our Investments:
OM Maya prides itself on a diverse and strategically selected investment portfolio, including companies across various sectors such as oncology diagnostics, medical devices, and synthetic biology.
Oncohost Ltd.
- Sector: Precision Oncology – Diagnostics
- Stage: Lead investors in seed round, with a board position in the company. · Website: Oncohost
- Overview: OncoHost is a pioneering commercial-stage precision oncology company aimed at understanding each patient’s unique response to therapy. The company addresses a critical challenge in clinical oncology: resistance to treatment. OncoHost’s PROphet® platform is backed by robust clinical evidence and strong intellectual property, positioning it to guide earlier and more informed therapeutic decisions.
NanoMedic Technologies
- Sector: Medical Devices
- Stage: Seed round (Spin-off of Nicast), with a board position in the company. · Website: NanoMedic
- Overview: Specializing in electrospinning technology, NanoMedic Technologies Ltd. focuses on the development and distribution of advanced medical devices. The company’s innovation in wound care solutions targets broad market applications, aiming to revolutionize patient care both in and outside of hospital settings.
Coral Smart Pool Inc.
- Sector: N/A
- Stage: Co-lead in seed round (spin-off of Coral detection systems), with a board position in the company. · Websites: Coral Smart Pool, MYLO
- Overview: Coral leads in integrating computer vision and machine learning technology for pool activity monitoring. With its groundbreaking AI Lifeguard System, MYLO, Coral enhances safety and enjoyment for residential pool owners by providing 24/7 monitoring and real-time risk detection.
Enzymit
- Sector: Synthetic Biology
- Stage: Seed investment through SPV, with a board observer position. · Website: Enzymit
- Overview: Enzymit is at the forefront of synthetic biology, combining advanced computational design with deep-learning technology. The company aims to introduce next-generation chemistry solutions to modern industries, leveraging innovation in biotechnology for sustainable and efficient processes.
We Venture Partners is a family office dedicated to supporting and investing in visionary entrepreneurs shaping the future of technology. We are committed to fostering innovation, driving growth, and generating meaningful returns.
